Oncology Research and Treatment

Papers
(The TQCC of Oncology Research and Treatment is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Highlights of Translational and Molecular Research Presented at the European Society for Medical Oncology Annual Meeting 202326
PharmaNews26
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Salvage Therapy of Relapsed/Refractory Germ Cell Tumors: A Single-Center Experience26
Polypharmazie - Wechselwirkungen der BTKi25
uGI: Biomaker-Cut-Offs in der Immunonkologie25
Front & Back Matter21
PharmaNews19
Front & Back Matter18
ED- und LD-SCLC: Studienergebnisse zum Einsatz von Durvalumab15
Follow-Up Time of Anal Cancer Screening among Women Living with HIV at High Risk of Developing Anal Cancer14
High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study14
Society Bulletins13
EGFR-Tyrosine Kinase Inhibitor Combined with Radiotherapy in 105 Patients of Lung Adenocarcinoma with Brain Metastasis: A Retrospective Study of Prognostic Factor Analysis10
Risk and Incidence of Infection with Bevacizumab in Non-Small-Cell Lung Cancer Patients: A Meta-Analysis9
Society Bulletins9
Aggressive B-Cell Lymphoma with Metastatic Spinal Cord Compression: Treat the Patient, Not the Disease9
Career and Professional Development for Young Oncologists9
Administration of Valproic Acid Improves the Survival of Patients with Glioma Treated with Postoperative Radiotherapy8
Platinum-Based Chemotherapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: Summary of Evidence and Application in Clinical Practice8
Prognosis and Therapy of Ovarian Cancer, Part 1: Patient Selection and Surgical Management in Advanced Ovarian Cancer – What Tools Do We Have to Make the Right Decision?8
Hochrisiko-MDS: Therapeutischer Ansatzpunkt Immunsystem7
Intradermal Naked DNA Vaccination by DNA Tattooing for Mounting Tumor-Specific Immunity in Stage IV Melanoma Patients: A Phase I Clinical Trial7
OnkoImmun 217
Clonal Evolution in Patients with Hormone Receptor Positive, HER-2 Negative Breast Cancer Treated with Chemotherapy or CDK4/6 Inhibitors7
Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center7
PharmaNews7
Body Composition and Inflammation as Emerging Sex-Specific Prognostic Factors in Patients with Advanced Cutaneous Melanoma Undergoing Immune Checkpoint-Inhibition Therapy: A Prospective Pilot Study7
PharmaNews6
DKK 2024: Acalabrutinib im Praxis-Check6
Sequential Geriatric Assessment in Older Patients with Colorectal Cancer during Chemotherapy: Subgroup Analysis of a Prospective, Multicenter Study EpiReal 756
PharmaNews6
Front & Back Matter6
Front & Back Matter6
Liquid Biopsy in Metastatic Breast Cancer: Path to Personalized Medicine6
Editing for Cure: in Conversation with Sylvie Lorenzen and Ralf-Dieter Hofheinz6
Guidelines of Onkopedia: What Is New? Locally Advanced Rectal Cancer6
Society Bulletins6
Front & Back Matter6
Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Ter: A Case Report5
Spirituality in Oncology: Relations between Spirituality, Its Facets, and Psychological and Demographic Factors in Cancer Patients in Germany5
Tumor-Infiltrating Lymphocytes, CAR-, and T-Cell Receptor-Modified T Cells in Solid Cancer Oncology5
PharmaNews5
Erratum5
Evaluating the Benefits and Challenges of Using Patient Preferences as a Tool for Clinical Decision Making in Oncology Multidisciplinary Team Meetings within the National Health Service: A Qualitative5
Real-World Survival Outcomes in Patients with Different Types of Cancer Managed with Immune Checkpoint Inhibitors5
Vorwort des DGHO-Vorstands5
Society Bulletins5
Capivasertib/Fulvestrant bei ER+/HER2– MBC5
Genomic Landscape of Circulating-Tumor DNA in a Diverse Cohort of Metastatic Breast Cancer Patients5
Epcoritamab: Indikationserweiterung für das FL5
NSCLC: RWE-Daten zur Sequenztherapie5
Effects of a Sound Intervention on Physical and Emotional Well-Being in Patients with Cancer: A Prospective Randomized Trial4
Therapiemanagement von Sacituzumab Govitecan4
Durvalumab auch bei Hirnmetastasen vorteilhaft4
Pan-HER Tyrosine Kinase Inhibitor Pyrotinib Enhances Radiosensitivity via ERK1/2 Pathway in HER2-Positive Gastric Cancer4
PharmaNews4
Society Bulletins4
PharmaNews4
Prelims4
Survivorship in Chimeric Antigen Receptor T-Cell Therapy Recipients: Infections, Secondary Malignancies, and Non-Relapse Mortality4
Prognosis and Therapy of Ovarian Cancer: Part 2 – the Shifting Landscape of Medical Treatment in Ovarian Cancer3
A Current Assessment of the Use of Complementary Medicine in German Cancer Patients: The CONKO 022 Investigation3
Modifications to Prostate Cancer Diagnosis following COVID-19 and Following Models3
Safety and Efficacy of Pharmacotherapy Containing the Second-Generation Integrase Inhibitors and Chemotherapy Drugs in AIDS-Related Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Analysi3
Risk and Prognosis of Subsequent Primary Gastric Cancer3
Society Bulletins3
Das inoperable NSCLC im Stadium III im Dialog3
Successful Liver Transplantation of Recurrent Fibrolamellar Carcinoma following Clinical and Pathologic Complete Response to Triple Immunochemotherapy: A Case Report3
ASH-Daten zu Wirksamkeit und Sicherheit von Teclistamab beim RRMM3
Erstlinien-IO-IO-Regime: 4-Jahres-OS-Rate bei 25%3
Next-Generation Sequencing of Circulating Tumor DNA Can Optimize Second-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer after Progression on anti-EGFR Therapy: Time to Rethink Our Approac3
Interview mit Prof. Paul G. Richardson, Boston, zu Melflufen3
Management of Advanced Penile Cancer3
Pirtobrutinib: Nicht-kovalente BTKi-Therapieoption beim MCL3
Multiples Myelom: Langzeitergebnisse der MAIA-Studie3
Perspectives for Cancer Care and Research in Central and Eastern Europe3
Prelims2
Pancreatic, Hepatic, and Biliary Tract Oncology Highlights from the European Society for Medical Oncology Annual Meeting 20232
Implementation of Communication Skills Training at Oncology Centers in Germany: Results of a Mixed-Methods Survey2
Society Bulletins2
Nomogram Based on the Dynamic Change in the Neutrophil-to-Lymphocyte Ratio for Predicting the Pathological Complete Response of Breast Cancer after Neoadjuvant Systemic Therapy2
Erweiterte Therapieoptionen bei EGFRm NSCLC2
PharmaNews2
HCC - Frühzeitiges Erkennen ermöglicht rasche und effektive Therapie2
PharmaNews2
Oncology in Europe2
Society Bulletins2
Improving Accuracy and Source Transparency in Responses to Soft Tissue Sarcoma Queries Using GPT-4o Enhanced with German Evidence-Based Guidelines2
Nintedanib und Docetaxel beim Adenokarzinom der Lunge2
Poor Outcome of Adult T-Cell Leukemia/Lymphoma with Current Available Therapy: An Experience of Two Centers2
PharmaNews2
Guidelines of Onkopedia: What Is New?2
Editing for Cure: In Conversation with Marie von Lilienfeld-Toal and Kathrin Heinrich2
Society Bulletins2
Recent Advances in Castleman Disease2
Psychological Stress in Breast Cancer Patients during the Course of a Pandemic Disease: Before and after the Availability of Vaccines2
Early versus Delayed Tumor-Specific Therapy and Survival in Patients with Lung Cancer: A Retrospective Study2
Identification and Validation of Cyclin A2 and Cyclin E2 as Potential Biomarkers in Small Cell Lung Cancer2
Breast Cancer Patients Are at Increased Risk of Developing Uterine Serous Cancer: Implications for Counseling – A SEER Analysis2
Front & Back Matter2
Society Bulletins2
Factors Associating with Bone-Only Metastasis in Chinese Breast Cancer Patients in the Absence of Anti-Human Epidermal Growth Factor Receptor 2-Targeted Therapy2
Geriatric Assessment Scale for Optimal Management of Gastric Cancer in Older Adults Who Underwent Gastrectomy: A Systematic Review2
Nivolumab plus Ipilimumab beim metastasierten Melanom2
Acknowledgement to Reviewers2
Society Bulletins2
Front & Back Matter2
A Randomized, Controlled Pilot Study to Evaluate the Immediate Effect of Targeted Exercise Therapy on Cancer-Related Fatigue in Cancer Survivors: The FatiGO Study2
OnkoImmun 192
ONKOPEDIA Guideline Updates “in a Nutshell” for the Readers of Oncology Research and Treatment2
35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, 13.–16. November 2022, Berlin2
Management of Patients Undergoing CAR-T Cell Therapy in Germany2
Society Bulletins1
The Leucine-Rich α2-Glycoprotein-1 Levels in Patients with Multiple Myeloma1
Leitlinien-Updates: Lorlatinib ist präferierter 1L-Standard beim ALK+ aNSCLC1
PharmaNews1
Disease Burden of Colorectal Cancer in China from 1990 to 2019: Age- and Sex-Specific Time Trends and 10-Year Forecast1
Acknowledgement to Reviewers1
Front & Back Matter1
Prelims1
PharmaNews1
Real-World Advances in Metastatic Pancreatic Cancer Treatment in the Pre-Molecular Era: A Retrospective Single-Center Analysis 2010–20181
Clinicopathological Features and Survival Trends of Non-Epithelial Ovarian Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database1
Stability of End-of-Life Care Wishes and Gender-Specific Characteristics of Outpatients with Advanced Cancer under Palliative Therapy: A Prospective Observational Study1
AbbVie: BioPharma-Unternehmen mit onkologischer Mission1
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted Therapies1
Beta-Thalassämie und Sichelzellkrankheit: Nutzenerfolg mit Exa-cel1
Stereotactic Radiotherapy in Early-Stage Breast Cancer in Neoadjuvant and Exclusive Settings: A Systematic Review1
ALL - Blinatumomab verbesserte die Prognose für Kinder1
Front & Back Matter1
Prognostic Significance of HER2 Positivity in Endometrium Cancer1
Society Bulletins1
Contents Vol. 47, 20241
Ovarian Cancer and Its Association with Endometriosis: A Narrative Review1
PharmaNews1
Impact of Epidural Anesthesia on the Outcome of Elderly Patients with Endometrial Cancer: Results of a Propensity Score-Matched Analysis1
Onkologische Patient*innen individuell behandeln und begleiten1
PharmaNews1
Society Bulletins1
Efficacy and Safety of Bevacizumab in Pretreated Metastatic Breast Cancer: A Systematic Review and Meta-Analysis1
Sarcoma Research with Cancer Registry Data: Data and Peculiarities of Germany in the Light of Other Countries1
Enhanced Survival with Lymphadenectomy in Early-Stage Metachronous Second Primary Lung Cancer: A Retrospective Analysis1
Navigating the Evolving Landscape of Advanced Genitourinary Cancer Treatment1
OnkoImmun 181
Front & Back Matter1
Adverse Effects and Functional Outcome after Salvage Lymph Node Dissection in Prostate Cancer1
Established and Experimental Systemic Treatment Options for Advanced Liposarcoma1
Quality Measurement for Soft Tissue Sarcomas in Germany: First Results of the Certified Sarcoma Centres1
0.076499938964844